BNP Paribas Has $33.30 Million Stock Holdings in Synopsys, Inc. $SNPS

BNP Paribas grew its position in Synopsys, Inc. (NASDAQ:SNPS) by 2.4% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 65,126 shares of the semiconductor company’s stock after buying an additional 1,535 shares during the period. Synopsys makes up 1.1% of BNP Paribas’ portfolio, making the stock its 26th largest position. BNP Paribas’ holdings in Synopsys were worth $33,304,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in SNPS. HighVista Strategies LLC increased its holdings in shares of Synopsys by 25.8% in the second quarter. HighVista Strategies LLC now owns 3,900 shares of the semiconductor company’s stock worth $1,999,000 after acquiring an additional 800 shares in the last quarter. NewEdge Advisors LLC grew its position in shares of Synopsys by 53.7% in the 2nd quarter. NewEdge Advisors LLC now owns 4,626 shares of the semiconductor company’s stock valued at $2,372,000 after purchasing an additional 1,616 shares during the period. Intact Investment Management Inc. increased its stake in Synopsys by 11.1% during the 2nd quarter. Intact Investment Management Inc. now owns 2,000 shares of the semiconductor company’s stock worth $1,025,000 after purchasing an additional 200 shares in the last quarter. Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna acquired a new stake in Synopsys during the 2nd quarter worth approximately $733,000. Finally, State Street Corp lifted its stake in Synopsys by 1.2% in the second quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock valued at $3,725,362,000 after buying an additional 85,662 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Buying and Selling at Synopsys

In other news, CAO Sudhindra Kankanwadi sold 9,873 shares of the company’s stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the sale, the chief accounting officer owned 20,520 shares in the company, valued at $10,278,468. This represents a 32.48% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 0.62% of the stock is owned by company insiders.

Synopsys Trading Up 2.1%

Shares of NASDAQ:SNPS opened at $475.83 on Thursday. The company’s 50-day moving average price is $435.91 and its two-hundred day moving average price is $504.68. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.62 and a quick ratio of 1.51. The stock has a market capitalization of $88.39 billion, a PE ratio of 37.35, a price-to-earnings-growth ratio of 5.78 and a beta of 1.16.

Synopsys (NASDAQ:SNPS) last released its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter in the previous year, the business earned $3.40 earnings per share. Synopsys’s quarterly revenue was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, equities analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently issued reports on SNPS. BNP Paribas assumed coverage on shares of Synopsys in a research report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price objective for the company. Zacks Research raised shares of Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Citigroup assumed coverage on Synopsys in a research note on Monday, November 24th. They issued a “buy” rating and a $580.00 price target on the stock. KeyCorp cut their price target on Synopsys from $590.00 to $575.00 and set an “overweight” rating on the stock in a report on Wednesday, December 3rd. Finally, Baird R W downgraded Synopsys from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 10th. Eleven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $550.67.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.